Myelin Oligodendrocyte Glycoprotein-IgG Contributes to Oligodendrocytopathy in the Presence of Complement, Distinct from Astrocytopathy Induced by AQP4-IgG

• 来源期刊: 神经科学通报（英文版）
• 年，卷（期）: 2019,（5）
• 页码范围: 853-866
• 页数: 14页
• 语种: 英文

摘要

Immunoglobulin G against myelin oligodendrocyte glycoprotein (MOG-IgG) is detectable in neuromyelitis optica spectrum disorder (NMOSD) without aquaporin4 IgG (AQP4-IgG),but its pathogenicity remains unclear.In this study,we explored the pathogenic mechanisms of MOG-IgG in vitro and in vivo and compared them with those of AQP4-IgG.MOG-IgG-positive serum induced complement activation and cell death in human embryonic kidney (HEK)-293T cells transfected with human MOG.In C57BL/6 mice and Sprague-Dawley rats,MOG-IgG only caused lesions in the presence of complement.Interestingly,AQP4-IgG induced astroglial damage,while MOG-IgG mainly caused myelin loss.MOG-IgG also induced astrocyte damage in mouse brains in the presence of complement.Importantly,we also observed ultrastructural changes induced by MOG-IgG and AQP4-IgG.These findings suggest that MOG-IgG directly mediates cell death by activating complement in vitro and producing NMOSD-like lesions in vivo.AQP4-IgG directly targets astrocytes,while MOG-IgG mainly damages oligodendrocytes.